Inhibition of creatine kinase activity from rat cerebral cortex by D-2-hydroxyglutaric acid in vitro

Neurochemistry International

Volumn 44, Issue 1, 2004, Pages 45-52

  Da Silva, Cleide G ^a   Bueno, Ana Rúbia F ^a   Schuck, Patrícia F ^a   Leipnitz, Guilhian ^a   Ribeiro, César A J ^a   Rosa, Rafael B ^a   Dutra Filho, Carlos S ^a   Wyse, Angela T S ^a   Wannmacher, Clóvis M D ^a   Wajner, Moacir ^a,b  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Brain metabolism; Creatine kinase; D 2 Hydroxyglutaric acid

Indexed keywords

CREATINE KINASE; CREATINE PHOSPHATE; DEXTRO 2 HYDROXYGLUTARIC ACID; GLUTARIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN METABOLISM; CELL FREE SYSTEM; CONCENTRATION RESPONSE; CYTOSOL; DEXTRO 2 HYDROXYGLUTARIC ACIDURIA; DRUG EFFECT; ENZYME ACTIVITY; ENZYME INHIBITION; HOMEOSTASIS; IN VITRO STUDY; INCUBATION TIME; METABOLIC DISORDER; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; OXIDATION; PRIORITY JOURNAL; RAT;

RATTUS NORVEGICUS;

EID: 0042328229     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(03)00098-6     Document Type: Article

References (47)

1. Aksenov M.I., Aksenova M.V., Payne R.M., Smith C.D., Markesbery W.R., Carney J.M. The expression of creatine kinase isoenzymes in neocortex of patients with neurodegenerative disorders: Alzheimer's and Pick's disease. Exp. Neurol. 146:1997;458-465.
2. Aksenov M., Aksenova M.V., Payne R.M., Trojanovski J.Q., Schmidt K.L., Carney J.M., Butterfield D.A., Markesbery W.R. Oxidation of cytosolic proteins and expression of creatine kinase BB in frontal lobes of Neurodegenerative disorders. Dement. Geriatr. Cogn. Disord. 10:1999;158-165.
3. Aksenov M., Aksenova M.V., Butterfield A.D., Markesbery W.R. Oxidative modification of creatine kinase BB in Alzheimer's disease brain. J. Neurochem. 74:2000;2520-2527.
4. Avrova N.F., Victorov I.V., Tyurin V.A., Zakharova I.O., Sokolova T.V., Andreeva N.A., Stelmaschuk E.V., Tyurina Y.Y., Gonchar V.S. Inhibition of glutamate-induced intensification of free radical reactions by gangliosides: possible role in their protective effect in rat cerebellar granule cells and brain synaptosomes. Neurochem. Res. 23:1998;945-952.
5. Bergmeyer, H.U., 1974. Methods of Enzymatic Analysis, 2nd ed. Academic Press, New York and London.
6. Bessman S.P., Carpenter C.L. The creatine-creatine phosphate energy shuttle. Annu. Rev. Biochem. 54:1985;831-862.
7. Burton G.W., Wronska U., Stone L., Foster D.O., Ingold K.U. Biokinetics of dietary RRR-α-tocopherol in the male guinea-pig at three dietary levels of vitamin C and two levels of vitamin E. Lipids. 25:1990;199-210.
8. Chalmers R.A., Lawson A.M., Watts R.W.E., Tavill A.S., Kamerling J.P., Hey E., Ogilvie D. D-2-Hydroxyglutaric aciduria: case report and biochemical studies. J. Inherit. Metab. Dis. 3:1980;11-15.
9. Cornish-Bowden A. A simple graphical method for determining the inhibition constants of mixed, uncompetitive and non-competitive inhibitors. Biochem. J. 137:1974;143-144.
10. David S.S., Shoemaker M., Haley B.E. Abnormal properties of creatine kinase in Alzheimer's disease brain: correlation of reduced enzyme activity and active site photolabelling with aberrant cytosol-membrane partitioning. Mol. Brain Res. 54:1998;276-287.
11. Dixon, M., Webb, E.C., 1964. Enzymes, 2nd ed. Longmans, London.
12. Eeg-Olofsson O. D-2-Hydroxyglutaric aciduria with cerebral, vascular and muscular abnormalities in a 14-year-old boy. J. Child Neurol. 15:2000;488-492.
13. Groof A.J.C., Smeets B., Groot Koerkamp M.J.A., Mul A.N., Janssen E.E.W., Tabak H.F., Wieringa B. Changes in mRNA expression profile underlie phenotypic adaptations in creatine kinase-deficient muscles. FEBS Lett. 506:2001;73-78.
14. Gross W.L., Bak M.I., Ingwall J.S., Arstall M.A., Smith T.W., Balligand J.L., Kelly R. Nitric oxide inhibits creatine kinase and regulates heart contractile reserve. Proc. Natl. Acad. Sci. U.S.A. 93:1996;5604-5609.
15. Halliwell, B., Gutteridge, J.M.C., 1999. Free Radicals in Biology and Medicine, 3rd ed. Oxford University Press, London.
16. Hamman B.L., Bittl J.A., Jacobus W.E., Aleen P.D., Spencer R.S., Tina R., Ingwall J.S. Inhibition of creatine kinase reaction decrease the contractile reserve of isolated rat hearts. Am. J. Physiol. 269:1995;H1030-H1036.
17. Hensley K., Hall N., Subramaniam R., Cole P., Harris M., Aksenova M.V., Aksenov M.Y., Gabbita S.P., Carney J.M., Lowell M., Markesbery W.R., Betterfield D.A. Brain regional correspondence between Alzheimer's disease histopathology biomarkers of protein oxidation. J. Neurochem. 65:1995;2146-2156.
18. Hertz L., Peng L. Energy metabolism at the cellular level of the CNS. Can. J. Physiol. Pharmacol. 70:1992;145-157.
19. Hoffman G.F., Meier-Augenstein W., Stocker S., Surtees R., Rating D., Nyhan W.L. Physiology and pathophysiology of organic acids in cerebrospinal fluid. J. Inherit. Metab. Dis. 16:1993;648-669.
20. Holtzman D., Khait I., Mulken R., Albred E., Rand T., Jensenm F., Kraft R. In vivo development of brain phosphocreatine in normal and creatine-treated rabbits pups. J. Neurochem. 73:1999;2477-2484.
21. Hughes B.P. A method for estimation of serum creatine kinase and its use in comparing creatine kinase and aldolase activity in normal and pathological sera. Clin. Chim. Acta. 7:1962;597-604.
22. Kölker S., Pawlak V., Ahlemeyer B., Okun J.G., Horster F., Mayatepek E., Krieglstein J., Hoffmann G.F., Kohr G. NMDA receptor activation and respiratory chain complex V inhibition contribute to neurodegeneration in D-2-hydroxyglutaric aciduria. Eur. J. Neurosci. 16:2002a;21-28.
23. Kölker S., Okun J.G., Ahlemeyer B., Wyse A.T.S., Hörster F., Wajner M., Kohlmüller D., Mayatepek E., Krieglstein J., Hoffmann G. Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons. J. Neurosci. Res. 68:2002b;424-431.
24. Konorev E., Hogg N., Kalyanaraman B. Rapid and irreversible inhibition of creatine kinase by peroxynitrite. FEBS Lett. 427:1998;171-174.
25. Liao R., Nascimben L., Friedrich J., Gawthmey J.K., Ingwall J.S. Decrease energy reserve in an animal model of dilated cardiomyopathy. Relationship to contractile performance. Circ. Res. 78:1996;893-902.
26. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-267.
27. Malcon C., Kaddurah-Daoh R., Beal M.F. Neuroprotective effects of creatine administration against NMDA and malonate toxicity. Brain Res. 860:2000;195-198.
28. Matthews R.T., Ferrante R.J., Klivenji P., Yang L., Klein A.M., Mueller G., Kaddwrah-Daouk R., Beal M.F. Creatine and cyclocreatine attenuate MPTP neurotoxicity. Exp. Neurol. 157:1999;142-149.
29. Meister A., Anderson M.E. Glutathione. Annu. Rev. Biochem. 52:1983;711-760.
30. Mekhfi H., Veksler V., Mateo P.H., Maupoil V., Rochette L., Ventura-Clapier R. Creatine kinase in the main target of reactive oxygen species in cardiac myofibrils. Circ. Res. 17:1996;1016-1027.
31. O'Gorman E., Beutner G., Wallimann T., Brdiczka D. Differential effects of creatine depletion on the regulation of enzyme activities and on creatine-stimulated mitochondrial respiration in skeletal muscle. Biochim. Biophys. Acta. 1276:1996;161-170.
32. Ramirez O., Jiménez E. Opposite transitions of chick brain catalytically active cytosolic creatine kinase isoenzymes during development. Int. J. Dev. Neurosci. 18:2000;815-823.
33. Saks V.A., Kuznetsov A.V., Kuprianov V.V., Miceli M.V., Jacobus W.E. Creatine kinase of rat heart mitochondria. The demonstration of functional coupling to oxidative phosphorylation in an inner membrane-matrix preparation. J. Biol. Chem. 260:1985;7757-7764.
34. Saupe K.W., Spindler M., Tian R., Ingwall J.S. Impaired cardiac energetics in mice lacking muscle-specific isoenzymes of creatine kinase. Circ. Res. 82:1998;898-907.
35. Shainberg A., Yagil G., Yaffe D. Alterations of enzymatic activities during muscle differentiation in vitro. Dev. Biol. 25:1971;1-29.
36. Shear D.A., Haik K.L., Dunbar G.L. Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats. Neuroreport. 11:2000;1833-1837.
37. Silva C.G., Ribeiro C.A.J., Leipnitz G., Dutra-Filho C.S., Wyse Â.T.S., Wannmacher C.M.D., Sarkis J.J.F., Jakobs C., Wajner M. Inhibition of cytochrome c oxidase activity in rat cerebral cortex and human skeletal muscle by D-2-hydroxyglutaric acid in vitro. Biochim. Biophys. Acta. 1586:2002;81-91.
38. Stachowiak O., Dolder M., Wallimann T., Richter C. Mitochondrial creatine kinase is prime target of peroxynitrite-induced modification and inactivation. J. Biol. Chem. 273:1998;16694-16699.
39. Stanimirovic D.B., Wong J., Ball R., Durkin J.P. Free radical-induced endothelial membrane dysfunction at the site of blood-brain barrier: relationship between lipid peroxidation, Na,K-ATPase activity, and 51Cr release. Neurochem. Res. 20:1995;1417-1427.
40. Tomimoto H., Yamamoto K., Homburger H.A., Yanagihara T. Immunoelectron microscopic investigation of creatine kinase BB-isoenzyme after cerebral ischemia in gerbils. Acta Neuropathol. 86:1993;447-455.
41. Van der Knaap M.S., Jakobs C., Hoffmann G.F., Nyhan W.L., Renier W.O., Smeitink J.A.M., Catsman-Berrevoets C.E., Hjalmarson O., Vallance H., Sugita K., Bowe C.M., Herrin J.T., Craigen W.J., Buist N.R.M., Brookfield D.S.K., Chalmers R.A. D-2-Hydroxyglutaric aciduria: biochemical marker or clinical disease entity? Ann. Neurol. 45:1999a;111-119.
42. Van der Knaap M.S., Jakobs C., Hoffman G.F., Duran M., Muntau A.C., Schweitzer S., Kelley R.I., Parrot-Rouland F., Amiel J., De Lonlay P., Rabier D., Eeg-Olofsson O. D-2-Hydroxyglutaric aciduria: further clinical delineation. J. Inherit. Metab. Dis. 22:1999b;404-413.
43. Wallimann T., Wyss M., Brdiczka D., Nicolay K. Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the 'phosphocreatine circuit' for cellular energy homeostasis. Biochem. J. 28:1992;121-140.
44. Wallimann T., Doler M., Schlattner U., Eder M., Hornemann T., Kraft T., Stolz M. Creatine kinase: an enzyme with central role in cellular energy metabolism. Magn. Reson. Mater. Phys. Biol. Med. 6:1998;116-119.
45. Watanabe H., Yamagucgi S., Saiki K., Shimizu N., Fukao T., Kondo N., Orii T. Identification of the D-enantiomer of 2-hydroxyglutaric acid in glutaric aciduria type II. Clin. Chim. Acta. 238:1995;115-124.
46. Wolosker H., Panizzutti R., Englender S. Inhibition of creatine kinase with S-nitrosoglutathione. FEBS Lett. 392:1996;274-276.
47. Yuan G., Kaneko M., Masuda H., Hon R.G., Kobayashi A., Yamazak N. Decrease in heart mitochondrial creatine kinase activity due to oxygen free radical. Biochim. Biophys. Acta. 140:1992;78-84.